NextPlat Corp. (NASDAQ:NXPL) Short Interest Update

NextPlat Corp. (NASDAQ:NXPL) saw a significant increase in short interest in March. As of March 13th, there was short interest totaling 955,043 shares, an increase of 84.3% from the February 26th total of 518,283 shares. Based on an average daily trading volume, of 4,872,892 shares, the days-to-cover ratio is presently 0.2 days. Approximately 5.7% of the shares of the stock are short sold.

NextPlat Stock Down 9.6%

Shares of NASDAQ:NXPL opened at $0.54 on Friday. The company has a 50 day moving average price of $0.56 and a two-hundred day moving average price of $0.66. The company has a market capitalization of $14.65 million, a PE ratio of -1.81 and a beta of 1.26. NextPlat has a 52 week low of $0.41 and a 52 week high of $1.11. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.80 and a current ratio of 3.56.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of NextPlat in a research report on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in NextPlat stock. Citadel Advisors LLC bought a new stake in NextPlat Corp. (NASDAQ:NXPL) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned approximately 0.19% of NextPlat at the end of the most recent quarter. Institutional investors and hedge funds own 1.30% of the company’s stock.

About NextPlat

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.